IDC reports drop in DR demand
Gross revenues fell 16.6% for digital radiography vendor IDC in the third quarter compared to the year earlier period.
Gross revenues fell 16.6% for digital radiography vendor IDC in the third quarter compared to the year earlier period. For the year, gross revenues were down 40.1% compared to the previous nine-month period. Executives blame the decline primarily on falling demand in the U.S. Despite shrinking revenues, however, the company pared its net loss in 3Q to $1.5 million from a net loss of $2.7 in the previous year 3Q, an improvement achieved by belt tightening measures that cut the quarter’s expenses by 44.4% to $1.5 million. Commenting on the third quarter 2009 results, IDC President and CEO Tom Boon said the results were below expectations, but noted that the company is continuing to cut costs and improve management processes.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.
